TITLE

Diagnosis of Pneumonia and Monitoring of Infection Eradication

AUTHOR(S)
Ruiz, M.; Arosio, C.; Salman, P.; Bauer, T.T.; Torres, A.
PUB. DATE
December 2000
SOURCE
Drugs;Dec2000, Vol. 60 Issue 6, p1289
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Pneumonia can be classified as community-acquired (CAP) or hospital-acquired (nosocomial). Both are frequent infections that demand a great amount of medical resources. The diagnosis of CAP is based on clinical signs and the presence of a pulmonary infiltrate visible on chest radiograph. For practical purposes, CAP has been classified as typical, with an acute onset in which the most representative micro-organism is Streptococcus pneumoniae, and atypical, with a subacute onset (Mycoplasma pneumoniae). Nevertheless, so far no studies have clearly demonstrated the utility of this classification in predicting the aetiology. Guidelines on CAP recommend associating the aetiology of CAP with comorbidity, age and severity. The microbiological diagnosis relies mainly on Gram stain and sputum culture, but this technique has disadvantages such as frequent contamination of the sample with oropharyngeal commensal flora, frequent sterile cultures associated with previous antibiotic treatment, and the fact that approximately 40% of patients are not able to expectorate. Other diagnostic techniques such as blood cultures, serological tests and fibreoptic bronchoscopy must be reserved for patients who are hospitalised, especially if they need admission to an intensive care unit. Compared with CAP, nosocomial pneumonia has major diagnostic problems due to the presence of other diseases able to mimic pneumonia and frequent bacterial colonisation of the lower respiratory tract. Most of the diagnostic techniques produce a high percentage of false-negative and false-positive results. This is especially true for ventilator-associated pneumonia. There is controversy over using a comprehensive aetiological work-up based on bronchoscopic techniques or only on quantitative culture of endotracheal aspiration. By contrast, there is consensus about the importance of the adequacy of empirical antibiotic treatment, since mortality rates are higher in patients who are inadequately treated. Once treatment of pneumonia has begun, it must be maintained for 48 to 72 hours because this is the minimum time to evaluate a clinical response. Antibacterial agents have to be adjusted according to microbiological findings. In nonresponding patients, pneumonia-related complications and the presence of multiresistant micro-organisms or non-covered pathogens must be ruled out.
ACCESSION #
9592881

 

Related Articles

  • Adult Patients With Nosocomial Pneumonia: Epidemiology, Diagnosis, and Treatment. Dalhoff, Klaus; Ewig, Santiago; Panning, Marcus; Kern, Winfried V.; Dettenkofer, Markus // Deutsches Aerzteblatt International;1/6/2014, Vol. 111 Issue 1/2, p10 

    A letter to the editor is presented in response to the article "Adult patients with nosocomial pneumonia-epidemiology, diagnosis and treatment" by K. Dalhoff and colleagues in the 2013 issue along with the authors' reply to the same.

  • Improving Surveillance Definitions for Ventilator-Associated Pneumonia in an Era of Public Reporting and Performance Measurement. Magill, Shelley S.; Fridkin, Scott K. // Clinical Infectious Diseases;2/1/2012, Vol. 54 Issue 3, p378 

    The author discusses the tools used by healthcare providers to prevent healthcare-associated infections (HAIs) and focuses on improving the methods for detecting ventilator-associated pneumonia (VAP). Author suggests that long term surveillance at regional and national level might help in...

  • Nosocomial infections due to Acinetobacter baumannii in a pediatric intensive care unit in Turkey. Özdemir, Halil; Kendirli, Tanıl; Ergün, Hüseyin; Çiftçi, Ergin; Tapışız, Anıl; Güriz, Haluk; Aysev, Derya; İnce, Erdal; Doğru, Ülker // Turkish Journal of Pediatrics;May/Jun2011, Vol. 53 Issue 3, p255 

    The aim of this study is to document the clinical characteristics and outcomes of Acinetobacter baumannii infections in pediatric patients in a pediatric intensive care unit (PICU) in TUrkey. The ages ranged from 1 month to 16 years with a mean age of 55.5 months, and the male-to-female ratio...

  • Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control. Antonelli, Massimo; Azoulay, Elie; Bonten, Marc; Chastre, Jean; Citerio, Giuseppe; Conti, Giorgio; Backer, Daniel; Lemaire, François; Gerlach, Herwig; Hedenstierna, Goran; Joannidis, Michael; Macrae, Duncan; Mancebo, Jordi; Maggiore, Salvatore M.; Mebazaa, Alexandre; Preiser, Jean-Charles; Pugin, Jerôme; Wernerman, Jan; Zhang, Haibo // Intensive Care Medicine;Feb2010, Vol. 36 Issue 2, p196 

    The article discusses several medical research studies related to intensive care medicine published in the periodical in 2009. It presents a study related to diagnosis and treatment of ventilator-associated pneumonia (VAP) using endotracheal aspirate (EA) cultures, another study on bacterial...

  • Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. Behnia, Mehrdad; Logan, Sharon C.; Fallen, Linda; Catalano, Philip // BMC Research Notes;2014, Vol. 7 Issue 1, p1 

    Background Nosocomial and ventilator-associated pneumonia (VAP) are causes of significant morbidity and mortality in hospitalized patients. We analyzed a) the incidence and the outcome of pneumonias caused by different pathogens in the intensive care unit (ICU) of a medium-sized twenty-four bed...

  • Diagnostic Techniques and Procedures for Establishing the Microbial Etiology of Ventilator-Associated Pneumonia for Clinical Trials: The Pros for Quantitative Cultures. Chastre, Jean; Trouillet, Jean-Louis; Combes, Alain; Luyt, Charles-Edouard // Clinical Infectious Diseases;8/1/2010 Supplement 1, Vol. 51, pS88 

    Use of only clinical criteria for enrolling patients in clinical trials leads to inclusion of many patients who have no pulmonary infection, which can make the evaluation of new treatment modalities difficult. Quantitative cultures of specimens obtained using bronchoscopic or nonbronchoscopic...

  • Pneumonia classification and healthcare-associated pneumonia: a new avenue or just a cul-de-sac? Woodhead, Mark // Thorax;Nov2013, Vol. 68 Issue 11, p985 

    In this article, the author focuses on Health Care-associated Pneumonia (HCAP) and classification of pneumonia. He informs that the HCAP has four patient subgroups including patients hospitalised in an acute care hospital, received chemotherapy and attended a haemodialysis clinic. He mentions...

  • Even experienced physicians may miss a diagnosis of pneumonia.  // Geriatrics;Apr95, Vol. 50 Issue 4, p61 

    Presents an abstract of the article `Interobserver Variability in the Interpretation of Chest Roentgenograms of Patients with Possible Pneumonia,' by M. Young and T.J. Marrie from `Archives of Internal Medicine' dated 1994.

  • Electronic `nose' sniffs out infections. Rothenberg, Robert S.; Barrett, Wayne M. // USA Today Magazine;Feb98, Vol. 126 Issue 2633, p5 

    Focuses on the computerized aroma-analysis device that is providing results in the detection of pneumonia in hospitalized patients. How the technique has potential as a method to detect lung infections; How doctors have long used the sense of smell as a diagnostic tool.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics